✦ LIBER ✦

A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer

✍ Scribed by Michael V. Seiden; Alan N. Gordon; Diane C. Bodurka; Ursula A. Matulonis; Richard T. Penson; Eddie Reed; Dave S. Alberts; Garry Weems; Michael Cullen; William P. McGuire III

Book ID: 113960288
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 112 KB
Volume: 101
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2005.09.036

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of single-agent gemcitabi

Phase II study of single-agent gemcitabine in heavily pretreated Japanese patients with recurrent ovarian cancer

✍ Yoh Watanabe; Eiji Koike; Hidekatsu Nakai; Tomomaro Etoh; Hiroshi Hoshiai 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 237 KB

Cytoreduction and Hyperthermic Intraperi

Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion in Women with Heavily Pretreated Recurrent Ovarian Cancer

✍ Ceelen, Wim P.; Nieuwenhove, Yves; Belle, Simon; Denys, Hannelore; Pattyn, Piet 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 350 KB

Phase II study of ecteinascidin 743 in h

Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma

✍ Caroline Laverdiere; E. Anders Kolb; Jeffrey G. Supko; Richard Gorlick; Paul A. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

## Abstract ## BACKGROUND Recurrent osteosarcoma is a drug‐resistant disease with a dismal prognosis. The objective of this Phase II study was to evaluate the activity of ecteinascidin 743 (ET‐743) as a salvage therapy in these patients. ## METHODS Patients with recurrent osteosarcoma who had re

A phase II study of weekly topotecan and

A phase II study of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine and ovarian cancers

✍ Divya Gupta; Ricky L. Owers; Mimi Kim; Dennis Yi-Shin Kuo; Gloria S. Huang; Shoh 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 189 KB

A phase II study to determine the effica

A phase II study to determine the efficacy and tolerability of intravenous ZD9331 in heavily pretreated patients with ovarian cancer

✍ J.S Rader; D Clarke-Pearson; M Moore; L Carson; R Holloway; M.-S Kao; I Wiznitze 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 147 KB

A phase II study of paclitaxel in heavil

A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer

✍ Smit, EF; Fokkema, E; Biesma, B; Groen, HJM; Snoek, W; Postmus, PE 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 852 KB